Research into mind-altering drugs is back. By Zoë CorbynYou don’t have to spend much time at the six-day second international Psychedelic Science conference in downtown Oakland to learn that not all its 1,900 attendees are academic scientists, and that few are strangers to the power...
By Dan OlsonST. PAUL, Minn. — To the untrained eye, a certain greenhouse of plants at the University of Minnesota’s St. Paul campus may seem like nothing special. But Dennis McKenna, an ethno-pharmacologist, sees much more than that.Some can cure disease, like the Madagascar periwinkle.“It...
Psilocybin, the active ingredient in magic mushrooms, is being explored as a therapeutic tool to improve the lives of people with a life-threatening illness. By Erica RexThis article was originally published with the title Calming a Turbulent Mind.Link to PREVIEW of article | Scientific American...
Once taboo, psychedelics are making an enlightening medical comebackby Jennifer Bleyer / GSAS ’12On a spring day in 2010, “Sandra,†then a 63-year-old ice-skating instructor with short graying hair and an impish smile, received her diagnosis: ovarian cancer, stage 1C. The rock-hard tumor growing inside...
Link to this article in Popular Science’s website, POPSCI...
The New York Times Sunday Magazine has published an outstandingly informative article on psilocybin research by Heffter Research Institute scientists Dr. Charles Grob, Dr. Roland Griffiths and Dr. Stephen Ross. Ms. Slater also features testimony from patient Pamela Sakuda, her husband and Heffter consultant Norbert...
Brazil’s, CIENCIA  (SCIENCE) has again profiled the Heffter Research Institute, this time focusing on President, and co-founder, Dr. Dave Nichols. The article written by Dr. Cibele Ruas reports on  Dr. Nichols extensive research on psycho-active substances....
The respected financial site, Bloomberg Businessweek,  has released an extremely positive article on the study of  hallucinations. The article features Heffter Board members Dr. Dave Nichols, Dr. Roland Griffiths, Dr. Charles Grob, and Dr. Stephen Ross. The Heffter Research Institute is also prominently mentioned as the...
The Los Angeles Times on November 29, 2011 featured a very positive survey article on the status of hallucinogenic research and the changing  perceptions concerning these compounds in the medical community.  As the Times states, “Hallucinogens and other street drugs are increasingly being studied for legitimate therapeutic...
The Heffter Research Institute is honored to present its Lifetime Achievement Award to Dr. Stanislav Grof. The award was presented to Dr. Grof at the Joshua Tree Retreat Center in Joshua Tree, California on September 23, 2011 by Heffter Board Member, Dr. Charles Grob. Dr. Grof is one of...
